Dr Reddy’s Earnings Plunge On German Unit Charge, Increased Generic Competition

NEW DELHI - Dr Reddy's Laboratories, India's second-biggest drugmaker, said third quarter earnings and revenues plunged on lower-than-expected earnings in Germany and increased competition as it changes its mix of generic drug products